Exclusivity of Research. Intel acknowledges that University may engage in other research within the Field of Research funded by public or private sources and conducted separately, and Intel shall have no rights hereunder to such other research or resulting intellectual property, provided that no Intel Intellectual Property or Confidential Information was relied upon.
Exclusivity of Research. During the Research Term, each Party agrees not to, and agrees to cause its Affiliates not to, (a) conduct any activity, either on its own, or for the benefit of, sponsored by, or pursuant to any type of corporate partnership with, any Third Party, that has as its goal or intent discovering, identifying, researching, developing or marketing Nicotinic Compounds (including without limitation any Collaboration Compounds) for use in the Field, except pursuant to this Agreement or the Second Collaboration Agreement, or (b) grant any license, either express or implied, or any option to license, to any Third Party to utilize any intellectual property Controlled by such Party or its Affiliates for the purpose of discovering, identifying, researching, developing or marketing Nicotinic Compounds for use in the Field, except to the extent expressly permitted by this Agreement or the Second Collaboration Agreement; provided, however, that a Party may terminate the foregoing covenant as it applies to such Party, as one of its remedies and not to the exclusion of any other remedy such Party may have, if the other Party materially violates its obligations under the foregoing covenant.
Exclusivity of Research. COMPANY acknowledges that UNIVERSITY may engage in other research within the Field of Research but outside the Research Plan of this Agreement, funded by public or private sources and conducted separately, and COMPANY shall have no rights hereunder to such other research or resulting Intellectual Property.
Exclusivity of Research. Intel acknowledges that NTU may engage in other research within the field of research funded by public or private sources and conducted separately, and Intel shall have no rights hereunder to such other research or resulting intellectual property, provided that no Intel Intellectual Property or Confidential Information was relied upon.
Exclusivity of Research. During the Research Term, neither Party ----------------------- will, except pursuant to this Agreement, conduct or fund, either by itself or at a Third Party, any research or Development activity specifically intended to identify, discover, synthesize or develop compounds using any of the Existing Compounds as leads for, or as the basis for, chemical discovery for use in the Primary Field.
Exclusivity of Research. During the term of this Agreement, and thereafter if Nitto purchases the share of Quark’s ownership of the jointly Owned IP and the grant of non-exclusive license of Quark Licensed IP in accordance with subsections 7.2 (iii)(a) through (d) or subsection 7.2 (iv)(c), or if Nitto terminates this Agreement because of Quark’s Change of Control or Quark’s material breach in accordance with subsection 7.2 (i) or 7.2 (ii) respectively, neither Quark nor any of its affiliates shall, directly or indirectly, whether on its own or with a third party, perform any research with respect to, or develop or commercialize, the Nitto Targets, Formulation, Products or Nitto Target-directed siRNA.
Exclusivity of Research. IgX understands that UNIVERSITY may be involved in similar research through other researchers on behalf of itself and others. UNIVERSITY shall be free to continue such research provided that it is conducted separately under funding separate from the Research Plan of Exhibit "A" and IgX shall not gain any rights via this Agreement to such other research.
Exclusivity of Research. During the Sponsored Research Term and for a period of six (6) months following the expiration of the Sponsored Research Term, Dr. Lee, except as expressly permitted under Xxxxxxxs 3.9 and/or 3.10 hereof, will not participate (as a researcher, consultant or advisor) in any research sponsored or otherwise funded by a commercial entity (except a Party) which is intended to characterize previously-Discovered TGF-(beta) Factors (except for GDF 1), and Discover and characterize new Factors, in the TGF-(beta) Superfamily. During the Sponsored Research Term and for such time as they are engaged in the Discovery and characterization of TGF-(beta) Factors in (or in collaboration with) Dr. Lee's JHU laboratory, the JHU faculty, stxxxxxx, xellows and employees who have signed an Invention and Disclosure Agreement shall give JHU immediate notice of any formal affiliations they are negotiating or may have (as researchers, consultants or advisors) with a commercial entity (except GI) which is intended to discover, identify and/or characterize Factors in the TGF-(beta) Superfamily. JHU, acting through Dr. Lee, shall describe to GI any such notice xxx xxceives under an Invention and Disclosure Agreement, and thereafter, JHU shall have no further obligation, PROVIDED that such Invention and Disclosure Agreement remains in effect, and FURTHER PROVIDED, that JHU, acting through Dr. Lee, notifies such commercial entity of txx xxxxtence of such Invention and Disclosure Agreement between JHU and such JHU faculty, student, fellow or employee.
Exclusivity of Research. During the Research Term, each Party agrees not to, and agrees to cause its Affiliates not to: (a) conduct any activity, either on its own, or for the benefit of, sponsored by, or pursuant to any type of corporate partnership with, any Third Party, that has as its goal or intent discovering, identifying, researching, developing or marketing chemical compounds [********] receptors [********] (including, without limitation, any Alliance Compounds) for use in the Field; or (b) grant any license, either express or implied, or any option to license, to any Third Party to utilize any intellectual property Controlled by such Party or its Affiliates for the purpose of discovering, identifying, researching, developing or marketing chemical compounds [********] receptors [********] for use in the Field, in each case except pursuant to this Agreement or the Original Agreement; provided, that: (i) the restrictions set forth in this Section 2.11 shall be limited to the Primary Indications; (ii) the restrictions set forth in this Section 2.11 shall apply to Targacept only for so long as both (A) Aventis shall be using commercially reasonable efforts (as further described in Section 3.5), which efforts shall be not less than those used by Aventis with respect to the development of other compounds of comparable commercial significance, to develop and commercialize a “Collaboration Compound” for the corresponding “Indication” in each “Major Pharmaceutical Market” (all such terms as defined in the Original Agreement); and (B) the Original Agreement is in full force and effect with respect to such Indication; and (iii) a Party may terminate the foregoing covenant as it applies to such Party, as one of its remedies and not to the exclusion of any other remedy such Party may have, if the other Party materially violates its obligations under the foregoing covenant.
Exclusivity of Research. TELIK acknowledges that UNIVERSITY may engage in other research within the Field of Research with respect to the Selected Targets, funded by public or private sources and conducted separately, and TELIK shall have no rights hereunder to such other research or resulting Intellectual Property.
